Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
VERO 
Venus Concept Inc (VERO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: VERO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $10.6
1 Year Target Price $10.6
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -80.36% | Avg. Invested days 15 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.42M USD | Price to earnings Ratio - | 1Y Target Price 10.6 |
Price to earnings Ratio - | 1Y Target Price 10.6 | ||
Volume (30-day avg) 1 | Beta 0.06 | 52 Weeks Range 2.10 - 8.93 | Updated Date 10/15/2025 |
52 Weeks Range 2.10 - 8.93 | Updated Date 10/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -44.79 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -68.77% | Operating Margin (TTM) -57.62% |
Management Effectiveness
Return on Assets (TTM) -28.35% | Return on Equity (TTM) -1161.04% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 37682077 | Price to Sales(TTM) 0.07 |
Enterprise Value 37682077 | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA -3.16 | Shares Outstanding 1859123 | Shares Floating 1843860 |
Shares Outstanding 1859123 | Shares Floating 1843860 | ||
Percent Insiders 0.82 | Percent Institutions 13.78 |
Upturn AI SWOT
Venus Concept Inc
Company Overview
History and Background
Venus Concept Inc. was founded in 2009 and is a global medical aesthetic technology leader, developing, commercializing, and delivering minimally invasive and non-invasive medical aesthetic technologies and related practice enhancement services.
Core Business Areas
- Aesthetic Technologies: Develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic technologies.
- Practice Enhancement Services: Offers a range of services designed to improve the profitability and efficiency of medical aesthetic practices.
Leadership and Structure
Venus Concept Inc. is led by a team of executives with experience in the medical aesthetics industry. The organizational structure includes sales, marketing, research and development, and operations departments.
Top Products and Market Share
Key Offerings
- Venus Versa: A multi-application platform that provides a wide range of non-invasive aesthetic procedures. Competitors: Candela, Lumenis, Cutera. Revenue not publicly broken down per product. Market share for company is mentioned below.
- Venus Viva: A fractional radio frequency system for skin resurfacing and wrinkle reduction. Competitors: Lutronic, Endymed, Alma Lasers. Revenue not publicly broken down per product. Market share for company is mentioned below.
- Venus Legacy: A non-invasive body contouring and skin tightening device. Competitors: BTL Aesthetics, Cynosure, InMode. Revenue not publicly broken down per product. Market share for company is mentioned below.
Market Dynamics
Industry Overview
The medical aesthetics industry is experiencing growth driven by increasing demand for non-invasive and minimally invasive cosmetic procedures. Key trends include technological advancements, rising disposable incomes, and an aging population.
Positioning
Venus Concept Inc. focuses on providing versatile and affordable aesthetic solutions, targeting medical aesthetic practices seeking to expand their service offerings. It is positioned as a provider of technologies that offer a good return on investment.
Total Addressable Market (TAM)
The global medical aesthetics market is expected to reach hundreds of billions in the coming years. Venus Concept is positioned to capitalize on this TAM through its diversified product portfolio and global reach.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Global distribution network
- Focus on affordability and ROI
- Strong brand recognition
- Recurring revenue model through consumables
Weaknesses
- High debt levels
- Inconsistent profitability
- Competition from larger players
- Limited R&D resources compared to competitors
Opportunities
- Expanding into new geographic markets
- Developing new applications for existing technologies
- Acquiring complementary technologies
- Growing demand for non-invasive procedures
Threats
- Intense competition
- Technological obsolescence
- Economic downturns
- Regulatory changes
Competitors and Market Share
Key Competitors
- ALGN
- ISRG
- ZBH
Competitive Landscape
Venus Concept Inc. faces intense competition from larger and more established players in the medical aesthetics industry. Its competitive advantage lies in its versatile product portfolio and focus on affordability.
Growth Trajectory and Initiatives
Historical Growth: Consult SEC filings and public reports for historical growth trends.
Future Projections: Consult analyst reports for future growth projections.
Recent Initiatives: Focus on strategic partnerships and product enhancements.
Summary
Venus Concept is a smaller player in the large medical aesthetics market. Its global presence and versatile product offerings are strengths. Its profitability, high debt and strong competition in the market are challenges for the company. Venus Concept needs to manage their debt effectively and continue innovating to stay ahead.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Financial Databases
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is estimated and may not be precise. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Venus Concept Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2012-11-05 | CEO & Director Mr. Rajiv Kanishka Liyanaarchchie De Silva | ||
Sector Healthcare | Industry Medical Devices | Full time employees 292 | Website https://www.venus.ai |
Full time employees 292 | Website https://www.venus.ai | ||
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.